Correlation Engine 2.0
Clear Search sequence regions

  • adherens junction (2)
  • cancer (1)
  • catenins (2)
  • cellular (1)
  • humans (1)
  • kinases (2)
  • MAPK (5)
  • p120 catenin (5)
  • protein human (1)
  • protein kinases (2)
  • RAS (2)
  • regulates (2)
  • rna (1)
  • RPS6KA1 protein (1)
  • RSK (7)
  • signal (1)
  • skin cancer (1)
  • Sizes of these terms reflect their relevance to your search.

    The RAS/mitogen-activated protein kinase (MAPK) signaling pathway regulates various biological functions, including cell survival, proliferation and migration. This pathway is frequently deregulated in cancer, including melanoma, which is the most aggressive form of skin cancer. RSK (p90 ribosomal S6 kinase) is a MAPK-activated protein kinase required for melanoma growth and proliferation, but relatively little is known about its function and the nature of its cellular partners. In this study, we used a proximity-based labeling approach to identify RSK proximity partners in cells. We identified many potential RSK-interacting proteins, including p120ctn (p120-catenin), which is an essential component of adherens junction (AJ). We found that RSK phosphorylates p120ctn on Ser320, which appears to be constitutively phosphorylated in melanoma cells. We also found that RSK inhibition increases melanoma cell-cell adhesion, suggesting that constitutive RAS/MAPK signaling negatively regulates AJ integrity. Together, our results indicate that RSK plays an important role in the regulation of melanoma cell-cell adhesion. © 2020 Méant et al.


    Antoine Méant, Beichen Gao, Geneviève Lavoie, Sami Nourreddine, Flora Jung, Léo Aubert, Joseph Tcherkezian, Anne-Claude Gingras, Philippe P Roux. Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion. Molecular & cellular proteomics : MCP. 2020 Jan;19(1):50-64

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 31678930

    View Full Text